Filing Details
- Accession Number:
- 0000874015-17-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-20 17:34:25
- Reporting Period:
- 2017-10-18
- Accepted Time:
- 2017-10-20 17:34:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Ionis Pharmaceuticals Inc | IONS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1073385 | Lynne B Parshall | C/O Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-18 | 7,785 | $14.69 | 33,526 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-18 | 7,785 | $65.00 | 25,741 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-10-18 | 8,333 | $39.87 | 34,074 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-10-18 | 8,333 | $65.00 | 25,741 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-10-18 | 7,785 | $0.00 | 7,785 | $14.69 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2017-10-18 | 8,333 | $0.00 | 8,333 | $39.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-01-02 | 2020-01-29 | No | 4 | M | Direct |
| 74,167 | 2015-01-02 | 2021-01-01 | No | 4 | M | Direct |
Footnotes
- Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 8/8/2017.
- Grant of 1/2/2014 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/2015. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 20,625 shares per year. Following this transaction, the option was exercisable as to 69,010 on 10/18/2017.
Billionaire Hedge Funds
